Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator

Medicine (Baltimore). 2018 Dec;97(49):e13216. doi: 10.1097/MD.0000000000013216.

Abstract

To determine whether glycated hemoglobin and mean arterial pressure (MAP) during thrombolysis are prognostic factors of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) for acute ischemic stroke (AIS).A total of 125 AIS patients, who received rt-PA intravenous thrombolysis in our hospital, were included into the present study, and divided into good prognosis group and poor prognosis group. Univariate and multivariate logistic regression analyses were used to determine the prognostic factors of AIS treated by rt-PA thrombolysis, Spearman correlation analysis was used to analyze the correlation of the accumulated cigarette consumption in the smoking subgroup and glycated hemoglobin in the diabetic subgroup with the prognosis after intravenous thrombolysis and the symptomatic intracranial hemorrhage (sICH).Univariate analysis revealed that the interval from onset to thrombolysis, baseline National Institutes of Health Stroke Scale (NIHSS) score, MAP during thrombolysis and DRAGON score were prognostic factors. Multivariate logistic regression analysis revealed that baseline NIHSS score and MAP during thrombolysis were independent prognostic factors for rt-PA thrombolysis. Furthermore, the glycated hemoglobin index was positively correlated with the incidence of sICH.The NIHSS score before thrombolysis and MAP during thrombolysis were independent factors for the prognosis of AIS treated by thrombolysis. The higher the glycated hemoglobin index of diabetic patients, the more likely they are to develop sICH, the glycated hemoglobin index was negatively correlated with the prognosis after intravenous thrombolysis. The accumulated cigarette consumption was negatively correlated with the prognosis after intravenous thrombolysis.

MeSH terms

  • Administration, Intravenous
  • Adult
  • Aged
  • Arterial Pressure
  • Biomarkers / blood
  • Brain Ischemia / blood*
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / epidemiology
  • Diabetes Complications / blood
  • Diabetes Complications / epidemiology
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Hemoglobins / metabolism
  • Humans
  • Incidence
  • Intracranial Hemorrhages / blood
  • Intracranial Hemorrhages / epidemiology
  • Male
  • Middle Aged
  • Prognosis
  • Recombinant Proteins / therapeutic use
  • Smoking / blood
  • Smoking / epidemiology
  • Stroke / blood*
  • Stroke / drug therapy*
  • Stroke / epidemiology
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Biomarkers
  • Fibrinolytic Agents
  • Hemoglobins
  • Recombinant Proteins
  • Tissue Plasminogen Activator